SCIENTIFIC-PRACTICAL JOURNAL

| укр | рус |

 

 


No4-5(2) 2019

Back to the issue


DOI 10.37219/2528-8253-2019-4-19

Bogomolov A.Ye., Dubchak L.I.
Comparison of diagnostic parameters of methods for determination of sensitization to allergen D. pteronyssinus in patients with respiratory allergic diseases
Bogomolov Artemy Yevgenievich
Candidate of Medical Sciences, Associate Professor of the Department of Phthisiatry with a course of clinical immunology and allergology of Vinnitsa National Pirogov memorial Medical University
e-mail: art.bogomolov@gmail.com
https://orcid.org/0000-0002-5336-4858

Dubchak Lyudmila Ivanovna
Department of Phthisiatry with a course of clinical immunology and allergology of Vinnitsa National Pirogov memorial Medical University, assistant
email: doubchak_l@gmail.com
https://orcid.org/0000-0002-7438-8592

Abstract

The aim of the study was to evaluate the diagnostic parameters of various methods for determining allergy sensitization to the dust mite allergen Dermatophagoides pteronyssinus in patients with respiratory allergic diseases – allergic rhinitis and bronchial asthma.
Materials and methods: During the study, 88 patients with allergic rhinitis and / or atopic asthma were examined with three different methods of specific allergic diagnosis (in vivo and in vitro) according to the recommendations of the ethics committee of the Pirogov Vinnitsa National Medical University, all of which were out of acute period. Inclusion criteria were a diagnosis of allergic rhinitis (both intermittent and persistent) and / or atopic asthma. The prick-test was conducted according to the classic test method by normative documents with commercial allergen extracts. Western blots for the determination of IgE levels were performed using RIDA AllergyScreen test systems (R-Biopharm AG, Darmstadt, Germany) and Euroline (Euroimmun).
Results and discussion: The results of two systems for the determination of specific IgE to D. Pteronyssinus by the Rida AllergyScreen and Euroline methods have a systematic difference of values (-1.27 kU / l).
There is a good agreement between the results of skin testing with D. Pteronyssinus allergens and the detection of specific IgE by the Rida AllergyScreen method, and there is a satisfactory agreement between the results of skin testing with D. Pteronyssinus allergens and detection of specific IgE by the Euroline method.
According to the results of the curve of detection of specific IgE by AllergyScreen method for determination of sensitization to allergen D. Pteronyssinus has excellent diagnostic significance (AUC=0,953), detection of specific IgE by Euroline method for determination of sensitization to allergen D. Pteronyssinus – good AUC=0,7.

Keywords

prick-test, allergy, immunoblotting, IgE.


Reference

  1. Almqvist C, Ekberg S, Rhedin S, Fang F, Fall T, Lundholm C. Season of birth, childhood asthma and allergy in a nationwide cohort-Mediation
    through lower respiratory infections. Clin Exp Allergy. 2019 Nov 29. doi: 10.1111/cea.13542. [Epub ahead of print].
  2. Tsutsumi H. Respiratory tract infection and allergy. Arerugi. 2019; 68(9): 1121-5. doi: 10.15036/arerugi.68.1121.
  3. Roche N, Anzueto A, Bosnic Anticevich S, Kaplan A, Miravitlles M, et al. The importance of real-life research in respiratory medicine: manifesto of
    the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization. Eur Respir
    J. 2019 Sep 19;54(3). pii: 1901511. doi: 10.1183/13993003.01511-2019. Print 2019 Sep.
  4. Bousquet J, SchÑŒnemann HJ, Togias A, Bachert C, Erhola M, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020; 145(1): 70-80.e3. doi: 10.1016/j.jaci.2019.06.049. Epub 2019 Oct 15.
  5. Braido F, Baiardini I, Blasi F, Pawankar R, Canonica GW. Adherence to asthma treatments: 'we know, we intend, we advocate'. Curr Opin Allergy
    Clin Immunol. 2015 Feb; 15(1): 49-55. doi: 10.1097/ACI.0000000000000132.
  6. Ьnal D. Effects of Perennial Allergen Immunotherapy in Allergic Rhinitis in Patients with/without Asthma: A-Randomized Controlled Real-Life Study. Int Arch Allergy Immunol. 2020 Jan 8:1-8. doi: 10.1159/000504916. [Epub ahead of print].
  7. Cox LS, Murphey A, Hankin C. The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma. Immunol Allergy Clin North Am. 2020 Feb;40(1):69-85. doi: 10.1016/j.iac.2019.09.003.
  8. Pfaar O, Agache I, de Blay F, Bonini S, Chaker AM, Durham SR, et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy. 2019
    Dec;74 Suppl 108:3-25. doi: 10.1111/all.14077.
  9. Virchow JC. Allergen immunotherapy (AIT) in asthma. Semin Immunol. 2019 Dec;46:101334. doi: 10.1016/j.smim.2019.101334. Epub 2019 Nov 8.
 

© 2019, Public Organization «Ukrainian Scientific Medical Society of Otorhinolaryngologists»